107 related articles for article (PubMed ID: 1538492)
1. Salvage surgery plus androgen deprivation for radioresistant prostatic adenocarcinoma.
Ahlering TE; Lieskovsky G; Skinner DG
J Urol; 1992 Mar; 147(3 Pt 2):900-2. PubMed ID: 1538492
[TBL] [Abstract][Full Text] [Related]
2. Androgen deprivation with salvage surgery for radiorecurrent prostate cancer: results at 5-year followup.
Garzotto M; Wajsman Z
J Urol; 1998 Mar; 159(3):950-4; discussion 954-5. PubMed ID: 9474190
[TBL] [Abstract][Full Text] [Related]
3. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
4. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Carrie C; Hasbini A; de Laroche G; Richaud P; Guerif S; Latorzeff I; Supiot S; Bosset M; Lagrange JL; Beckendorf V; Lesaunier F; Dubray B; Wagner JP; N'Guyen TD; Suchaud JP; Créhange G; Barbier N; Habibian M; Ferlay C; Fourneret P; Ruffion A; Dussart S
Lancet Oncol; 2016 Jun; 17(6):747-756. PubMed ID: 27160475
[TBL] [Abstract][Full Text] [Related]
5. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
[TBL] [Abstract][Full Text] [Related]
6. The role of radical surgery in the management of radiation recurrent and large volume prostate cancer.
Moul JW; Paulson DF
Cancer; 1991 Sep; 68(6):1265-71. PubMed ID: 1873780
[TBL] [Abstract][Full Text] [Related]
7. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
Berenguer Sánchez A
Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
[No Abstract] [Full Text] [Related]
8. Limits of observational data in determining outcomes from cancer therapy.
Giordano SH; Kuo YF; Duan Z; Hortobagyi GN; Freeman J; Goodwin JS
Cancer; 2008 Jun; 112(11):2456-66. PubMed ID: 18428196
[TBL] [Abstract][Full Text] [Related]
9. Salvage surgery for radiation failure in prostate cancer.
Pontes JE; Montie J; Klein E; Huben R
Cancer; 1993 Feb; 71(3 Suppl):976-80. PubMed ID: 8428347
[TBL] [Abstract][Full Text] [Related]
10. Avoidance and management of positive surgical margins before, during and after radical prostatectomy.
Bott SR; Kirby RS
Prostate Cancer Prostatic Dis; 2002; 5(4):252-63. PubMed ID: 12627209
[TBL] [Abstract][Full Text] [Related]
11. [Surveillance after prostate cancer radiotherapy].
Supiot S; Rio E; Clément-Colmou K; Bouchot O; Rigaud J
Cancer Radiother; 2011 Oct; 15(6-7):540-5. PubMed ID: 21795093
[TBL] [Abstract][Full Text] [Related]
12. Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer.
Wadasaki K; Kaneyasu Y; Kenjo M; Matsuura K; Murakami Y; Hashimoto Y; Ito K; Kiriu H; Ito A
Int J Clin Oncol; 2007 Feb; 12(1):37-41. PubMed ID: 17380439
[TBL] [Abstract][Full Text] [Related]
13. Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited.
Vaidya A; Soloway MS
J Urol; 2000 Dec; 164(6):1998-2001. PubMed ID: 11061900
[TBL] [Abstract][Full Text] [Related]
14. Total cystoprostatectomy in the treatment of locally advanced prostate carcinoma.
Sato K; Tsuchiya N; Habuchi T; Satoh S; Shimoda N; Kato T
Aktuelle Urol; 2003 Jul; 34(4):259-61. PubMed ID: 14566679
[TBL] [Abstract][Full Text] [Related]
15. Population-based analysis of salvage radical prostatectomy with examination of factors associated with adverse perioperative outcomes.
Pearce SM; Richards KA; Patel SG; Pariser JJ; Eggener SE
Urol Oncol; 2015 Apr; 33(4):163.e1-6. PubMed ID: 25708953
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience.
Servoll E; Sæter T; Vlatkovic L; Nesland JM; Waaler G; Axcrona K
Scand J Urol; 2015 Jun; 49(3):218-23. PubMed ID: 25428750
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
[TBL] [Abstract][Full Text] [Related]
18. Salvage radical prostatectomy for radiorecurrent adenocarcinoma of the prostate.
Neerhut GJ; Wheeler T; Cantini M; Scardino PT
J Urol; 1988 Sep; 140(3):544-9. PubMed ID: 3411670
[TBL] [Abstract][Full Text] [Related]
19. [Last resort surgical management of postradiation urinary cystitis after external beam radiation for prostate cancer: a monocentric analysis].
Seisen T; Rouprêt M; Phé V; Bosset PO; Parra J; Drouin SJ; Simon JM; Chartier-Kastler E
Cancer Radiother; 2013; 17(4):282-7. PubMed ID: 23810305
[TBL] [Abstract][Full Text] [Related]
20. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
Pearse M; Fraser-Browne C; Davis ID; Duchesne GM; Fisher R; Frydenberg M; Haworth A; Jose C; Joseph DJ; Lim TS; Matthews J; Millar J; Sidhom M; Spry NA; Tang CI; Turner S; Williams SG; Wiltshire K; Woo HH; Kneebone A
BJU Int; 2014 Mar; 113 Suppl 2():7-12. PubMed ID: 24894850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
